- Title
- COMBAT: A study of Cu-SAR-BBN and Cu-SAR-BBN for identification and treatment of GRPr-expressing metastatic castrate-resistant prostate cancer
- Creators
- Luke T. Nordquist - Urology Cancer Center, PC, Omaha, NE, United StatesEva Lengyelova - Clarity Pharmaceuticals, Eveleigh, NSW, AustraliaFrankis Almaguel - Loma Linda UniversityBrandon Robert Mancini - BAMF Health, Grand Rapids, MI, United StatesHong Song - Stanford UniversityAndrew J. Armstrong - Duke UniversityAmado J. Zurita - The University of Texas MD Anderson Cancer CenterMonique Anderson - Clarity Pharmaceuticals, Eveleigh, NSW, AustraliaMichelle Parker - Clarity Pharmaceuticals, Eveleigh, NSW, AustraliaRobert M. Miller - Clarity Pharmaceuticals, Eveleigh, NSW, AustraliaAndrei Iagaru - Stanford University
- Publication Details
- Journal of clinical oncology, Vol.42, pp.TPS247-TPS247
- Identifiers
- 991006262301602656
- Academic Unit
- Radiology
- Language
- English
- Resource Type
- Journal article
Journal article
COMBAT: A study of Cu-SAR-BBN and Cu-SAR-BBN for identification and treatment of GRPr-expressing metastatic castrate-resistant prostate cancer
Journal of clinical oncology, Vol.42, pp.TPS247-TPS247
02/01/2024
Metrics
1 Record Views